Regulation of tumor cell apoptotic sensitivity during the cell cycle (Review)
1Drug Discovery Program, H. Lee Moffitt Cancer Center & Research Institute, Department of Biochemistry & Molecular Biology, College of Medicine, University of South Florida, Tampa, FL 33612, USA.
Abstract:
Understanding how current chemotherapeutic modalities induce apoptosis is critical to designing better anti-cancer agents. This review is concerned with how pharmacological agents induce tumor cell apoptosis in a cell cycle-dependent manner. Recent experiments demonstrate that expression of several apoptotic regulatory proteins (such as Bcl-2, Bax, p53, and Survivin) are differentially regulated according to the phases of the cell cycle. This cell cycle-dependent regulation in turn contributes to increased drug sensitivity in different phases of the cell cycle. It is therefore likely that the cell cycle-dependent expression of cell death proteins plays a role in regulating chemosensitivity and apoptotic commitment of human tumor cells.
Insights
Chemotherapy drugs kill cancer cells by triggering apoptosis, a process that varies with the cell cycle. Understanding this cell cycle dependence can improve anti-cancer drug design and effectiveness.
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Background:
- Chemotherapeutic agents are crucial for cancer treatment.
- Apoptosis, or programmed cell death, is a key mechanism targeted by chemotherapy.
- Understanding the nuances of apoptosis induction is vital for developing more effective anti-cancer drugs.
Purpose of the Study:
- To review how pharmacological agents induce tumor cell apoptosis in a cell cycle-dependent manner.
- To explore the role of cell cycle regulation in chemosensitivity.
- To highlight the significance of apoptotic regulatory proteins in cancer treatment.
Main Methods:
- Literature review of recent experimental findings.
- Analysis of cell cycle-dependent regulation of apoptotic proteins.
- Examination of the relationship between cell cycle phase and drug sensitivity.
Main Results:
- Expression of key apoptotic regulatory proteins (Bcl-2, Bax, p53, Survivin) varies across cell cycle phases.
- This differential regulation impacts tumor cell sensitivity to chemotherapeutic agents.
- Cell cycle-dependent protein expression influences apoptotic commitment in human tumor cells.
Conclusions:
- Cell cycle-dependent regulation of apoptotic proteins is a critical factor in chemotherapy efficacy.
- Targeting specific cell cycle phases may enhance the effectiveness of anti-cancer drugs.
- Further research into cell cycle-dependent apoptosis can lead to improved cancer therapies.
More Related Videos
12:02Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
Related Concept Videos
Negative Regulator Molecules
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
